Based on our experience of the clinical and research utility of blood NfL in multiple sclerosis, NfL and/or GFAP may be used for allocation of rehabilitative resources, and selection of participants for clinical trials of neuro‐restorative therapies, and monitoring the response to such therapies.50 Here, GFAP is linked to multiple sclerosis.